Physician profile

Ryan D Gholson

Obstetrics · Owasso, OK

NPI 1285951186

$758.42

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8.55

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $407.03 2019-2022
Davol INC. $119.17 2020-2021
Therapeuticsmd, INC. $72.74 2019-2021
Kci USA, INC. $49.57 2020
Biohaven Pharmaceutical Holding Company Ltd. $22.77 2022
Hologic Sales and Service, LLC $19.08 2021
Ethicon US, LLC $16.05 2022
Merck Sharp & Dohme LLC $14.76 2020
Mylan Pharmaceuticals INC. $14.46 2021
Pfizer INC. $14.24 2019
Organon LLC $8.55 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ryan D Gholson

$758.42

in general payments reported 2019-2025

Years
2019-2024
Top company
Abbvie INC.

https://glasscript.com/doctor/912910/ryan-d-gholson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.